2000
DOI: 10.1093/jac/46.1.125
|View full text |Cite
|
Sign up to set email alerts
|

Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999

Abstract: Susceptibility to quinupristin/dalfopristin and other antibiotics was studied for clinical isolates of vancomycin-resistant enterococci (VRE) referred by UK hospitals between January 1997 and June 1999. Single isolates of VRE from 858 patients in 136 hospitals were received, of which 76% were Enterococcus faecium and 21% were Enterococcus faecalis, the remainder comprising minor species. Most isolates were multi-resistant. After allowing for the effect of blood, which raised the MICs of quinupristin/dalfoprist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(8 citation statements)
references
References 8 publications
0
8
0
Order By: Relevance
“…Busani et al. (2004), as well as Johnson et al., 2000; also found high rates in E. faecalis from poultry, but this cannot explain the lower values in conventional keepings. A spontaneous mutation of the rpo ‐gene is reported for rifampicin‐resistant E. faecium (Enne et al., 2004), however, existence of similar mechanisms in E. faecalis remains unknown.…”
Section: Discussionmentioning
confidence: 84%
“…Busani et al. (2004), as well as Johnson et al., 2000; also found high rates in E. faecalis from poultry, but this cannot explain the lower values in conventional keepings. A spontaneous mutation of the rpo ‐gene is reported for rifampicin‐resistant E. faecium (Enne et al., 2004), however, existence of similar mechanisms in E. faecalis remains unknown.…”
Section: Discussionmentioning
confidence: 84%
“…It is inactive against E. faecalis and is bacteriostatic against E. faecium [30]; the lack of bactericidal activity may compromise its clinical and bacteriological activity. Currently, less than 4% of clinical isolates are resistant to quinupristin/dalfopristin, as defined by a minimum inhibitory concentration greater than 4 μg.ml −1 [80, 93]. Synergism has been noted when quinupristin/dalfopristin is combined with either doxycycline or rifampicin [94, 95].…”
Section: Gram‐positive Organismsmentioning
confidence: 99%
“…VRE outbreaks are mostly caused by two predominant enterococcal species, namely Enterococcus faecalis and Enterococcus faecium , whereas vancomycin‐resistant organisms of other species appear only sporadically [1,2,4,5]. Thus, Enterococcus raffinosus is usually represented by few isolates in VRE survey studies or collections [6–11]. To our knowledge, the only description of clonal spread of vancomycin‐resistant E. raffinosus concerned a US hospital between December 1995 and February 1996, where it affected four patients and was detected post factum [12].…”
Section: Introductionmentioning
confidence: 99%